MeiraGTx Holdings (MGTX) Cash from Operations (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Cash from Operations of 46590000.0 for Q4 2025, up 300.16% on a YoY basis from 11642748.06 in Q4 2024, and up 482.2% quarter-over-quarter from 12190000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) Cash from Operations (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Cash from Operations for 9 years, with the latest figure at 46590000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations rose 300.16% year-over-year to 46590000.0; the trailing twelve-month figure through Dec 2025 stood at 46400000.0 (up 55.6% YoY), and the FY2025 full-year result was 46400000.0, up 55.6% from the prior year.
- Cash from Operations for Q4 2025 stood at 46590000.0, up from 12190000.0 in the prior quarter.
- The five-year high for Cash from Operations was 46590000.0 in Q4 2025, with the low at 43972000.0 in Q2 2025.
- Historically, Cash from Operations has averaged 16994400.0 across 5 years, with a median of 20993500.0 in 2021.
- Annual changes were most pronounced in 2023 — Cash from Operations plunged 350.61% — and 2025, when it jumped 300.16%.
- MeiraGTx Holdings' Cash from Operations stood at 18828000.0 in 2021, then sank by 186.4% to 16267000.0 in 2022, then rose by 10.57% to 14547000.0 in 2023, then slumped by 60.01% to 23276000.0 in 2024, then soared by 300.16% to 46590000.0 in 2025.
- The last three Cash from Operations figures came in at 46590000.0 (Q4 2025), 12190000.0 (Q3 2025), and 43972000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 46.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.59 Mn |
| Dec 31, 2025 | 46.59 Mn |
| Sep 30, 2025 | -12.19 Mn |
| Sep 30, 2025 | -12.19 Mn |
| Jun 30, 2025 | -43.97 Mn |
| Jun 30, 2025 | -43.97 Mn |
| Mar 31, 2025 | -36.83 Mn |
| Mar 31, 2025 | -36.83 Mn |
| Dec 31, 2024 | -23.28 Mn |
| Dec 31, 2024 | -23.28 Mn |
| Sep 30, 2024 | -25.02 Mn |
| Sep 30, 2024 | -25.02 Mn |
| Jun 30, 2024 | -19.46 Mn |
| Jun 30, 2024 | -19.46 Mn |
| Mar 31, 2024 | -36.74 Mn |
| Mar 31, 2024 | -36.74 Mn |
| Dec 31, 2023 | -14.55 Mn |
| Dec 31, 2023 | -14.55 Mn |
| Sep 30, 2023 | -24.41 Mn |
| Sep 30, 2023 | -24.41 Mn |